{"": [92, 100, 0], "Background": [101, 345, 0], "Methods": [346, 463, 0, 7514, 16521, 1], "Findings": [464, 1346, 0], "Interpretation": [1347, 1533, 0], "Funding": [1534, 2212, 0], "Research in Context": [2213, 3594, 0], "Introduction": [3595, 7513, 0], "Study subjects": [7523, 9745, 0], "Ethical statement": [9746, 9980, 0], "Cell lines": [9981, 10412, 0], "Enzyme-linked immunosorbent assays (ELISA)": [10413, 11009, 0], "Pseudotyped viral neutralization assay": [11010, 12572, 0], "Peptide pools": [12573, 13238, 0], "Intracellular cytokine staining (ICS)": [13239, 15457, 0], "Statistical analysis": [15458, 16368, 0], "Role of funding source": [16369, 16521, 0], "Safety profiles of BNT162b2 and CoronaVac in Hong Kong vaccinees": [16531, 17688, 0], "Humoral and cellular immune responses induced by BNT162b2 and CoronaVac": [17689, 22171, 0], "NAbs against SARS-CoV-2 VOCs among BNT162b2 and CoronaVac vaccinees": [22172, 25505, 0], "Vaccine-induced NAbs against VOCs and T cell responses in the memory phase": [25506, 27710, 0], "Correlation analysis of vaccine-induced humoral and cellular immune responses": [27711, 29430, 0], "Results": [16522, 29430, 1], "Discussion": [29431, 36581, 0], "Declaration of interest": [36582, 36651, 0]}